Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 9, 2014, Pages 2369-2375

  Jagielski, Tomasz ^a   BakuŁa, Zofia ^a   Roeske, Katarzyna ^a   Kamiński, MichaŁ ^a   Napiórkowska, Agnieszka ^b   Augustynowicz Kopeć, Ewa ^b   Zwolska, Zofia ^b   Bielecki, Jacek ^a  

^a UNIVERSITY OF WARSAW   (Poland)

^b NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

First line anti TB drugs; M. tuberculosis; Multidrug resistance; Sequence analysis; Spoligotyping; TB; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; BACTERIAL DNA; TUBERCULOSTATIC AGENT;

ADULT; AGED; AHPC GENE; ALLELE; ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; FEMALE; GENE LOCUS; HUMAN; INHA GENE; KASA GENE; KATG GENE; MALE; MINIMUM INHIBITORY CONCENTRATION; MSHA GENE; MULTIDRUG RESISTANT TUBERCULOSIS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; NAT GENE; NDH GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLAND; POLYMERASE CHAIN REACTION; PREVALENCE; PROMOTER REGION; STRUCTURAL GENE; DNA SEQUENCE; DRUG EFFECTS; EVALUATION STUDY; GENOTYPE; GENOTYPING TECHNIQUE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MOLECULAR GENETICS; MULTIDRUG RESISTANCE; PROCEDURES; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ANTITUBERCULAR AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENES, BACTERIAL; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; ISONIAZID; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; MYCOBACTERIUM TUBERCULOSIS; POLAND; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84905975703     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku161     Document Type: Article

References (31)

1. World Health Organization and International Union Against Tuberculosis and Lung Disease (WHO/IUATLD). Global Project on Anti-Tuberculosis Drug Resistance Surveillance 2002-2007: Anti-Tuberculosis Drug Resistance in the World: 4th Global Report. Geneva, Switzerland: WHO, 2008.
2. Afanas'ev MV, Ikryannikova LN, Il'ina EN et al. Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation. J Antimicrob Chemother 2007; 59: 1057-64.
3. Bakonyte D, Baranauskaite A, Cicenaite J et al. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania. Antimicrob Agents Chemother 2003; 47: 2009-11.
4. Guo H, Seet Q, Denkin S et al. Molecular characterization of isoniazidresistant clinical isolates of Mycobacterium tuberculosis from the USA. J Med Microbiol 2006; 55: 1527-31.
5. Hazbón MH, Brimacombe M, Bobadilla del Valle M et al. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 2006; 50: 2640-9.
6. Herrera L, Valverde A, Saiz P et al. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical strains isolated in the Philippines. Int J Antimicrob Agents 2004; 23: 572-6.
7. Kiepiela P, Bishop KS, Smith AN et al. Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Tuber Lung Dis 2000; 80: 47-56.
8. Zhang M, Yue J, Yang YP et al. Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. J Clin Microbiol 2005; 43: 5477-82.
9. Kelley CL, Rouse DA, Morris SL. Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 1997; 41: 2057-8.
10. Ramaswamy SV, Reich R, Dou SJ et al. Single nucleotide polymorphisms in genes associatedwith isoniazid resistance in Mycobacteriumtuberculosis. Antimicrob Agents Chemother 2003; 47: 1241-50.
11. Cardoso RF, Cardoso MA, Leite CQ et al. Characterization of ndh gene of isoniazid resistant and susceptible Mycobacterium tuberculosis isolates from Brazil. Mem Inst Oswaldo Cruz 2007; 102: 59-61.
12. Lee AS, Teo AS, Wong SY. Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 2001; 45: 2157-9.
13. Coelho MB, Costa ER, Vasconcellos SE et al. Sequence and structural characterization of tbnat gene in isoniazid-resistant Mycobacterium tuberculosis: identification of new mutations. Mutat Res 2011; 712: 33-9.
14. Brossier F, Veziris N, Truffot-Pernot C et al. Molecular investigation of resistance to the antituberculous drug ethionamide in multidrugresistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2011; 55: 355-60.
15. Jagielski T, Augustynowicz-Kopeć E, Zozio T et al. Spoligotype-based comparative population structure analysis of multidrug-resistant and isoniazid-monoresistant Mycobacterium tuberculosis complex clinical isolates in Poland. J Clin Microbiol 2010; 48: 3899-909.
16. Augustynowicz-Kopeć E, Zwolska Z, Jaworski A et al. Drug-resistant tuberculosis in Poland in 2000: second national survey and comparison with the 1997 survey. Int J Tuberc Lung Dis 2003; 7: 645-51.
17. van Embden JDA, Cave MD, Crawford JT et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406-9.
18. Luo T, Zhao M, Li X et al. Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, China. Antimicrob Agents Chemother 2010; 54: 1075-81.
19. Ramaswamy SV, Dou SJ, Rendon A et al. Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. J Med Microbiol 2004; 53: 107-13.
20. Hillemann D, Kubica T, Rü sch-Gerdes S et al. Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany. Antimicrob Agents Chemother 2005; 49: 1229231.
21. Tracevska T, Jansone I, Broka L et al. Mutations in the rpoB and katG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia. J Clin Microbiol 2002; 40: 3789-92.
22. Pym AS, Saint-Joanis B, Cole ST. Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect Immun 2002; 70: 4955-60.
23. Jagielski T, Grzeszczuk M, Kamiń ski M et al. Identification and analysis of mutations in the katG gene in multidrug-resistant Mycobacterium tuberculosis clinical isolates. Pneumonol Alergol Pol 2013; 81: 298-307.
24. Clemente WT, Soares Lima SS, Palaci M et al. Phenotypic and genotypic characterization of drug-resistant Mycobacterium tuberculosis strains. Diagn Microbiol Infect Dis 2008; 62: 199-204.
25. Bertrand T, Eady NA, Jones JN et al. Crystal structure of Mycobacterium tuberculosis catalase-peroxidase. J Biol Chem 2004; 279: 38991-9.
26. Cardoso RF, Cooksey RC, Morlock GP et al. Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil. Antimicrob Agents Chemother 2004; 48: 3373-81.
27. Perdigão J, Macedo R, João I et al. Multidrug-resistant tuberculosis in Lisbon, Portugal: a molecular epidemiological perspective. Microb Drug Resist 2008; 14: 133-43.
28. Sreevatsan S, Pan X, Zhang Y et al. Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities. Antimicrob Agents Chemother 1997; 41: 600-6.
29. Sholto-Douglas-Vernon C, Sandy J, Victor TC et al. Mutational and expression analysis of tbnat and its response to isoniazid. J Med Microbiol 2005; 54: 1189-97.
30. Samper S, Iglesias MJ, Rabanaque MJ et al. Systematic molecular characterization of multidrug-resistant Mycobacterium tuberculosis complex isolates from Spain. J Clin Microbiol 2005; 43: 1220-7.
31. Mäkinen J, Marjamä ki M, Haanperä-Heikkinen M et al. Extremely high prevalence of multidrug resistant tuberculosis in Murmansk, Russia: a population-based study. Eur J Clin Microbiol Infect Dis 2011; 30: 1119-26.